Dr Benjamin George transforms cancer care in rural Nebraska, ensuring accessible, high-quality treatment for patients in ...

Luveltamab tazevibulin, a novel ADC, showed encouraging responses in platinum-resistant ovarian cancer, with a 32% ORR and a ...

A recent study reveals promising results for CLL patients using zanubrutinib and venetoclax, highlighting effective ...

Benjamin George, MD, currently serving as the medical director of oncology at Community Hospital in McCook, Nebraska, and ...

Datopotamab deruxtecan received FDA approval for HR+/HER2– breast cancer, improving progression-free survival and overall ...

Marija Balic, MD, discusses the design and mechanism of the Oncodetect tumor-informed circulating tumor DNA assay for ...

Marija Balic, MD, discusses challenges that remain to the widespread implementation of MRD-guided patient management in TNBC.

In a new observational study published in Cancer, commonly prescribed chronic medications did not affect the efficacy of ...

DESTINY-Endometrial02 is a phase 3 trial assessing T-DXd as an adjuvant treatment for HER2-expressing endometrial cancer, ...

During a live event, Kathryn E. Beckermann, MD, PhD, and participants discussed whether risk stratification factors into the ...

The MCED test shows similar performance in cancer survivors and the general population, with a PPV of 50% and high ...

FOLFIRINOX chemotherapy is feasible in selected elderly patients with pancreatic ductal adenocarcinoma, though toxicity ...